Opinion|Videos|September 20, 2024
The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
Let’s conclude by discussing our perspectives on the future of CLL treatment.
- How do you envision the CLL patient experience evolving in the coming years? What improvements in care and quality of life do you hope to see? How do you hope emerging therapies and research will address these gaps?
- Based on your experience, what excites you most about the future of CLL management? How do you think the role of patients in their care decisions will continue to evolve?
Advertisement
Related to this article
A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.
She was diagnosed with stage 4 primary mediastinal B-cell lymphoma (PMBCL), a type of non-Hodgkin lymphoma that starts in the center of the chest, at 29.
Jyoti Malhotra, MD, MPH on first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to Yale Cancer Center.
Dr. Maureen McEvoy explains breast cancer surgery options, reconstruction, recovery and how to close gaps in access to care.
For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
A cancer survivor reflects on losing her hair during chemotherapy, the emotional impact of hair loss and what growing it back taught her about healing, identity and life.
After a lung cancer diagnosis, one Bronx writer reflects on faith, survivorship and learning that healing isn't a finish line, but a daily journey.
Dr. David DiBardino explains how intratumoral therapy is being studied to deliver treatment directly into tumors and potentially enhance radiation in patients with locally advanced non-small cell lung cancer.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
We Eat Bagels Before Cancer Treatment. Here’s Why.
3
Expert Says Blood Cancer Care Is Moving Past Chemotherapy
4
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
5